Q1 FY27: standalone loss widens, consolidated turns negative

Emphasis Of MatterGoing ConcernPat NegativeRevenue DeclineExceptional ItemResults View source PDF Explain this filing

SYSTMTXC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹60.70

prior close

₹59.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-2.1% vs market

Stockbroking & Allied peers, median of 38sector+0.3%-2.5% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.5 pts less than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.4

10m

-2.4

15m

+0.0

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1-0.1-2.1+0.3-2.5

Next day

-1.2-0.2-0.9+0.0-1.2

-2.1+0.1-2.2+0.0-2.1

-4.1+0.3-4.4+0.3-4.4

-1.2+0.4-1.5+0.8-2.0

-2.4+0.5-2.9+0.2-2.6

-3.1+0.3-3.4-0.3-2.8

15d

-4.6+1.9-6.5+0.9-5.5

+17.1+2.2+15.0+0.6+16.5

+22.7-1.2+23.8+0.4+22.3

—————

UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 38Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q1 net loss widened to Rs 618.90 lakh from Rs 351.69 lakh YoY; revenue fell to Rs 382.03 lakh from Rs 585.70 lakh. Consolidated PAT swung to a loss of Rs 489.39 lakh from a profit of Rs 1,045.96 lakh, even as revenue rose to Rs 5,892.92 lakh. 41st AGM on Sept 22, 2026. MD Nikhil Khandelwal re-appointed for 3 years. Auditor flagged SEBI cancellation of subsidiary SCSPL registration as emphasis of matter.

Likely market impact

Losses widened sharply. SEBI regulatory matter on subsidiary SCSPL remains a key risk. MD re-appointment provides leadership stability.